
Molecule to Market: Inside the outsourcing space
by Raman Sehgal
Is this your podcast?Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Most discussed topics
Brands & references
Total monthly reach
Estimated from 13 chart positions in 13 markets.
By chart position
- 🇺🇸US · Life Sciences#1505K to 30K
- 🇪🇸ES · Life Sciences#5310K to 30K
- 🇰🇷KR · Life Sciences#6010K to 30K
- 🇮🇳IN · Life Sciences#6610K to 30K
- 🇮🇹IT · Life Sciences#8410K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
22K to 77K🎙 Daily cadence·268 episodes·Last published 1mo ago - Monthly Reach
Unique listeners across all episodes (30 days)
72K to 256K🇺🇸12%🇪🇸12%🇰🇷12%+10 more - Active Followers
Loyal subscribers who consistently listen
22K to 77K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
From 17 epsHost
Recent guests
Recent episodes
Meet the Supply Chain Wizard
Jul 10, 2026
59m 11s
Building a Canadian CDMO from grad school
Jul 3, 2026
59m 17s
From Big Pharma to Biotech CEO
Jun 26, 2026
53m 46s
From Lab to Boardroom at Sartorius
Jun 12, 2026
49m 31s
CDMO Live Europe: State of Contract Manufacturing 2026
May 29, 2026
34m 54s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Topics | Guests | Brands | Places | Keywords | Sponsor | Length | |
|---|---|---|---|---|---|---|---|---|---|
| 7/10/26 | pharmaceutical supply chainbiotechnology+4 | Evren Ozkaya | Supply Chain WizardSCW.AI+3 | — | supply chainpharma industry+5 | — | 59m 11s | ||
| 7/3/26 | drug developmentCDMO+5 | Lisa Studnicki Hunt | GL CHEMTEC | CanadaUS+1 | CDMOdrug development+5 | — | 59m 17s | ||
| 6/26/26 | drug developmentbiotechnology+4 | Rachel Sha | Terrestrial BioGenzyme+2 | Boston | biotechCEO+5 | — | 53m 46s | ||
| 6/12/26 | pharmaceutical supply chainbiotechnology+4 | René Fáber | SartoriusSartorius Stedim Biotech S.A. | BratislavaGermany | bioprocess solutionsbiologics+5 | — | 49m 31s | ||
| 5/29/26 | contract manufacturingdrug development+3 | Kaan-Fabian KekecKurt Nielson+2 | PharmaSourceMolecule to Market+1 | — | contract manufacturingdrug development+5 | Bora Pharmaceuticals | 34m 54s | ||
| 5/22/26 | drug developmentbiotechnology+4 | Fred FleitzJason Costigan+2 | Arrowhead PharmaceuticalsCorsera Health+3 | — | drug developmentRNA manufacturing+5 | Bora PharmaceuticalsCODE | 51m 24s | ||
| 5/15/26 | global supply chainspharmaceutical industry+4 | Daniel Hurni | Roche | — | supply chainBig Pharma+5 | — | 59m 58s | ||
| 5/8/26 | outsourcingdrug development+4 | Jennifer ChadwickFirelli Alonso+1 | Jennifer Chadwick ConsultingConsultFi Biologics LLC+2 | — | drug developmentoutsourcing+5 | Bora Pharmaceuticals | 56m 00s | ||
| 5/1/26 | drug developmentbiotechnology+4 | Steve Favaloro | GenezenBrammer Bio+2 | — | CGT CDMObiotech executive+4 | — | 58m 19s | ||
| 4/24/26 | outsourcingpharmaceutical supply chain+4 | Felipe Furiati | GrünenthalBain | BrazilIreland+2 | drug developmentsupply chain management+3 | — | 55m 37s | ||
| 4/17/26 | drug developmentexecutive leadership+4 | Tim Dietlin | ELIQUENT Life ScienceGHO Capital+2 | — | drug developmentexecutive search+5 | — | 46m 07s | ||
| 4/10/26 | cell and gene therapybiotechnology+4 | Sean Werner | BioLife SolutionsSexton Biotechnologies+3 | — | cell therapygene therapy+5 | — | 46m 39s | ||
| 4/3/26 | outsourcingdrug development+4 | Alessandro MaselliFranco Negron | CatalentSimtra BioPharma Solutions+1 | — | outsourcingdrug development+6 | — | 46m 23s | ||
| 3/30/26 | outsourcingdrug development+4 | Jake BehrmanDirk Lange+3 | Pyramid Pharmaten23+2 | — | drug developmentoutsourcing+5 | 3i | 52m 25s | ||
| 3/20/26 | drug developmentoutsourcing+3 | Greg Plunkett | Accelagen | AustraliaMelbourne | CROregulatory consulting+3 | — | 57m 23s | ||
| 3/13/26 | pharmaceutical manufacturingbiotechnology+3 | Joerg Ahlgrimm | SK pharmtecoLonza | East GermanyPhiladelphia+1 | CDMOpharmaceuticals+5 | — | 52m 44s | ||
| 3/6/26 | CDMOdrug development+4 | Nick FortinAnkit Gupta+12 | Kincell BioCodis+12 | — | CDMOdrug development+6 | Bora Pharmaceuticals | 26m 11s |
Showing 17 of 17
Pitch Fit is a Pro feature
See how bookable this show is for guests, which brands already advertise, the per-episode ad value, and the best-fit guest and sponsor profile. The numbers are blurred on the free plan.
How readily this show books outside guests like you.
How proven this show is for host-read sponsorships.
For Guests
ProFor Advertisers
ProUpgrade to Pro to unlock guest cadence, sponsor categories, fit scores, and per-episode ad value for this show.
Chart history for Molecule to Market: Inside the outsourcing space
Peaked at #21 in Finland, currently #21 in Finland.
| Market | Genre | Peak | Current | Trend |
|---|---|---|---|---|
| Finland | — | #21 | #21 | — |
| SA | — | #25 | #25 | — |
| Spain | — | #53 | #53 | — |
| PL | — | #55 | #55 | — |
| South Korea | — | #60 | #60 | — |
| India | — | #66 | #66 | — |
| Italy | — | #84 | #84 | — |
| France | — | #112 | #112 | — |
| TW | — | #133 | #133 | — |
| United States | — | #150 | #150 | — |
| Netherlands | — | #152 | #152 | — |
| SA | — | #161 | #161 | — |
| IL | — | #168 | #168 | — |
| Sweden | — | #191 | #191 | — |
| Finland | — | #200 | #200 | — |
Chart Positions
15 placements across 13 markets.
Chart Positions
15 placements across 13 markets.